Dashboard
Manage Tickers

ARCTArcturus Therapeutics Holdi...

Nasdaq arcturusrx.com


$ 30.94 $ -0.60 (-1.9 %)    

Friday, 14-Jun-2024 15:59:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 31
$ 31.25
$ 0.00 x 0
$ 0.00 x 0
$ 30.02 - $ 31.59
$ 17.52 - $ 45.00
360,785
na
833.25M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cathie-wood-led-ark-invest-sells-15m-worth-of-robinhood-shares-amid-muted-bitcoin-market--also-dumps-zoom-stock-worth-33m
Cathie Wood-Led Ark Invest Sells $1.5M Wor...
06/13/2024 03:22:25

Ark Invest, led by Cathie Wood, made significant trades on Wednesday involving Robinhood Markets Inc (NASDAQ:HOOD) and Zoom Vid...

cathie-wood-lead-ark-invest-dumps-76m-worth-of-robinhood-shares-amid-gamestop-buzz-bitcoin-choppiness
Cathie Wood-Lead Ark Invest Dumps $7.6M Wo...
06/11/2024 02:28:34

On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). ...

arcturus-inhaled-mrna-therapeutic-in-cystic-fibrosis-study-highlights-potential-amid-competitive-landscape-analyst
Arcturus' Inhaled mRNA Therapeutic In Cyst...
06/07/2024 18:44:44

Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, ...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
06/07/2024 16:31:05

arcturus-therapeutics-presents-phase-1-results-for-arct-032-at-european-cystic-fibrosis-conference
Arcturus Therapeutics Presents Phase 1 Res...
06/07/2024 14:30:59

ARCT-032 is safe and well tolerated with no serious adverse events (SAEs) in 36 study participants, including 4 adults with cys...

arcturus-therapeutics-early-cystic-fibrosis-trial-results-encouraging---analyst-cautiously-optimistic
Arcturus Therapeutics' Early Cystic Fibros...
05/28/2024 18:55:43

Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung ...

why-applied-dna-sciences-shares-are-trading-lower-by-around-68-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Applied DNA Sciences Shares Are Tradin...
05/28/2024 17:24:16

nvidia-insmed-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Nvidia, Insmed, Agios Pharmaceuticals And ...
05/28/2024 14:31:28

Core News & Articles
Market-Moving News for May 28th
05/28/2024 12:41:15

CORT: 41% | Corcept Therapeutics shares are trading higher after the company announced that its Phase 3 GRACE trial met its pri...

arcturus-therapeutics-reports-phase-1b-data-for-cystic-fibrosis-treatment
Arcturus Therapeutics Reports Phase 1b Dat...
05/28/2024 10:33:14

Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program Business Wire Arcturus to present new Phase ...

Core News & Articles
Achilles Therapeutics And Arcturus Therape...
05/22/2024 11:07:04

Core News & Articles
CSL and Arcturus Therapeutics Announce Nat...
05/20/2024 12:42:20

Data follow the approval of the world's first self-amplifying (sa-mRNA) COVID-19 vaccine for adults in Japan. These results...

canaccord-genuity-maintains-buy-on-arcturus-therapeutics-lowers-price-target-to-86
Canaccord Genuity Maintains Buy on Arcturu...
05/10/2024 18:30:57

Canaccord Genuity analyst Whitney Ijem maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and lowers the price target ...

elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential
Elon Musk Breaks Ranks With GOP By Praisin...
05/09/2024 09:01:47

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

arcturus-therapeutics-q1-eps-100-beats-119-estimate-sales-3801m-beat-1754m-estimate
Arcturus Therapeutics Q1 EPS $(1.00) Beats...
05/08/2024 20:03:35

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of...

hc-wainwright--co-reiterates-buy-on-arcturus-therapeutics-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Arct...
03/20/2024 10:44:28

HC Wainwright & Co. reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $60 price target.

the-analyst-verdict-arcturus-therapeutics-in-the-eyes-of-4-experts
The Analyst Verdict: Arcturus Therapeutics...
03/11/2024 12:01:29

canaccord-genuity-maintains-buy-on-arcturus-therapeutics-raises-price-target-to-87
Canaccord Genuity Maintains Buy on Arcturu...
03/11/2024 11:51:35

Canaccord Genuity analyst Whitney Ijem maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and raises the price target ...

hc-wainwright--co-reiterates-buy-on-arcturus-therapeutics-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Arct...
03/08/2024 14:42:42

HC Wainwright & Co. analyst Ed Arce reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $60 price ta...

recap-arcturus-therapeutics-q4-earnings
Recap: Arcturus Therapeutics Q4 Earnings
03/07/2024 21:05:07

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)